Akebia Therapeutics, Inc. (AKBA) financial statements (2020 and earlier)

Company profile

Business Address 245 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:148322318260139109
Cash and cash equivalents147105701875033
Short-term investments0217248738976
Other undisclosed cash, cash equivalents, and short-term investments 0 000
Receivables39173434 0
Inventory, net of allowances, customer advances and progress billings116114    
Inventory116114    
Other undisclosed current assets7166221
Total current assets:310468358296141110
Noncurrent Assets
Operating lease, right-of-use asset29
Property, plant and equipment1084310
Long-term investments and receivables     40
Long-term investments     40
Intangible assets, net (including goodwill)346383    
Goodwill5555    
Intangible assets, net (excluding goodwill)291328    
Deferred costs     1
Other noncurrent assets761372110
Other undisclosed noncurrent assets    0(41)
Total noncurrent assets:4625286421
TOTAL ASSETS:771997364300143111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1681945932129
Accounts payable39437222
Accrued liabilities1291515230105
Employee-related liabilities     2
Deferred revenue40
Debt 15    
Postemployment benefits liability     0
Deferred revenue and credits8582  
Contract with customer, liability57
Other undisclosed current liabilities     (2)
Total current liabilities:208266144114127
Noncurrent Liabilities
Long-term debt and lease obligation103     
Long-term debt, excluding current maturities76     
Operating lease, liability28
Liabilities, other than long-term debt638810111800
Deferred revenue and credits101118  
Deferred revenue33
Contract with customer, liability56
Deferred rent credit 3
Other liabilities30300000
Other undisclosed noncurrent liabilities27    
Total noncurrent liabilities:1689510111800
Total liabilities:376361245232127
Stockholders' equity
Stockholders' equity attributable to parent, including:39563611968131104
Common stock00    
Treasury stock, value    (0)(0)
Additional paid in capital1,1891,151494365293205
Accumulated other comprehensive loss (0)(0)(0)(0)(0)
Accumulated deficit(794)(514)(374)(297)(161)(101)
Other undisclosed stockholders' equity attributable to parent     0
Total stockholders' equity:39563611968131104
TOTAL LIABILITIES AND EQUITY:771997364300143111

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues3352081782 1
Revenue, net1782 1
Cost of revenue(145)(8)    
Cost of goods and services sold(109)(6)    
Gross profit:1902001782 1
Operating expenses(476)(378)(258)(138)(62)(38)
Other undisclosed operating loss     (1)
Operating loss:(286)(178)(80)(136)(62)(38)
Nonoperating income (expense)(1)0010 
Investment income, nonoperating   1  
Other nonoperating income (expense)(1)00(0)0 
Loss from continuing operations before equity method investments, income taxes:(287)(178)(80)(136)(61)(38)
Other undisclosed income from continuing operations before income taxes16    
Loss from continuing operations before income taxes:(286)(172)(80)(136)(61)(38)
Income tax benefit728    
Net loss:(280)(144)(80)(136)(61)(38)
Other undisclosed net income attributable to parent  3 11
Net loss attributable to parent:(280)(144)(77)(136)(61)(37)
Preferred stock dividends and other adjustments     (87)
Other undisclosed net loss available to common stockholders, basic     (0)
Net loss available to common stockholders, diluted:(280)(144)(77)(136)(61)(124)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(280)(144)(80)(136)(61)(38)
Other comprehensive loss     (0)
Comprehensive loss:(280)(144)(80)(136)(61)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent002(0)01
Comprehensive loss, net of tax, attributable to parent:(279)(143)(77)(136)(61)(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: